Mitochondrial DNA analysis: Polymorphisms and pathogenicity

Journal of Medical Genetics

Volumn 36, Issue 7, 1999, Pages 505-510

  Chinnery, Patrick F ^a   Howell, Neil ^b   Andrews, Richard M ^a   Turnbull, Douglass M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Alzheimer's disease; Leber's hereditary optic neuropathy; Mitochondrial DNA; Phylogenetic analysis

Indexed keywords

MITOCHONDRIAL DNA;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA POLYMORPHISM; GENE MUTATION; GENETIC DISORDER; HAPLOTYPE; HUMAN; PATHOGENICITY; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; REVIEW;

EID: 0032965396     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.36.7.505     Document Type: Review

References (65)

1. Ivanov PL, Wadhams MJ, Roby RK, Holland MM, Weedon VW, Parsons TJ. Mitochondrial DNA sequence heteroplasmy in the Grand Duke of Russia Georgij Romanov establishes the authenticity of the remains of Tsar Nicholas II. Nat Genet 1996;12:417-20.
2. Parsons TJ, Muniec DS, Sullivan K, et al. A high observed substitution rate in the human mitochondrial DNA control region. Nat Genet 1997;15:363-8.
3. Torroni A, Wallace DC. Mitochondrial DNA variation in human populations and implications for detection of mitochondrial DNA mutations of pathological significance. J Bioenerg Biomembr 1994;26:261 -71.
4. Wallace DC, Torroni A. American Indian prehistory as written in the mitochondrial DNA: a review. Hum Biol 1992;64:403-16.
5. Wallace DC. 1994 William Allan Award Address. Mitochondrial DNA variation in human evolution, degenerative disease, and aging. Am J Hum Genet 1995;57:201-23.
6. Watson E, Forster P, Richards M, Bandelt HJ. Mitochondrial footprints of human expansion in Africa. Am J Hum Genet 1997;61:691-704.
7. van Holst Pellakaan SM, Frommer M, Syed J, Boettcher B. Mitochondrial control-sequence variation in aboriginal Australians. Am J Hum Genet 1998;62:435-49.
8. Lynch M, Jarrell PE. A method for calibrating molecular clocks and its application to animal mitochondrial DNA. Genetics 1993;135:1197-208.
9. Wise CA, Sraml M, Rubinsztein DC, Easteal S. Comparative nuclear and mitochondrial genome diversity in humans and chimpanzees. Mol Biol Evol 1997;14:707-16.
10. Howell N, Kubacka I, Mackey DA. How rapidly does the human mitochondrial genome evolve? Am J Hum Genet 1996;59:501-9.
11. Yang Z. Among-site rate variation and its impact on phylogenetic analyses. Trends Ecol Evol 1996;11:367-72.
12. Jazin E, Soodyall H, Jalonen P, Lindholm E, Stone king M, Gyllensten U. Mitochondrial mutation rate revisited: hot spots and polymorphism. Nat Genet 1998;18:109-10.
13. Gibbins A. Calibrating the mitochondrial clock. Science 1998;279:28-9.
14. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290:457-65.
15. Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and puthogenesis. J Bioenerg Biomembr 1997;29:131-49.
16. Chinnery PF, Johnson M, Taylor RW, Lightowlers RN, Turnbull DM. A novel mitochondrial tRNA phenylalanine gene mutation presenting with acute rhabdomyolysis. Ann Neurol 1997;41:408-10.
17. Chinnery PF, Johnson MA, Taylor RW, Durward WF, Turnbull DM. A novel mitochondrial tRNA isoleucine gene mutation causing chronic progressive external ophthalmoplegia, Neurology 1997;49:1166-8.
18. Ile gene: studies in a patient presenting with chronic progressive external ophthalmoplegia and multiple sclerosis. Biochem Biophys Res Commun 1998;243:47-51.
19. Howell N. Human mitochondrial diseases: answering questions and questioning answers. Int Rev Cytol 1199;186:49-116.
20. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 1992;2:324-9.
21. Cortopassi G, Arnheim N. Detection of specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res 1990;275:169-80.
22. Corral-Debrinski M, Horton T, Lott MT, et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 1994;23:471-6.
23. Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res 1992;275:169-80.
24. Santorelli FM, Sciacco M, Tanji K, et al. Multiple mitochondrial DNA deletions in sporadic inclusion body. Ann Neurol 1996;39:789-95.
25. Blume G, Pestronk A, Frank B, Johns DR, Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. Brain 1997;120(pt 1):39-45.
26. Brierley EJ, Johnson MA, Lightowlers RN, James OFW, Turnbull DM. Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol 1998;43:217-23.
27. Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ribosomal RNA mutations associated with both antibiotic-induced and non-sydromic deafness. Nat Genet 1993;4:289-94.
28. Mackey DA, Oostra RJ, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet 1996;59:481-5.
29. Howell N, Kubacka I, Halvorson S, Howell B, McCullough DA, Mackey D. Phylogenetic analysis of the mitochondrial genomes from Leber hereditary optic neuropathy pedigrees. Genetics 1995;140:285-302.
30. Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Harding AE. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995;118(pt 2):319-37.
31. Pegoraro E, Carelli V, Zevianni M, et al. X-inactivation patterns in female Leber's hereditary optic neuropathy patients do not support a strong X-linked determinant. Am J Med Genet 1996;61:356-62.
32. Howell N. Leber hereditary optic neuropathy: mitochondrial mutations and degeneration of the optic nerve. Vision Res 1997;37:3495-507.
33. Chalmers RM, Harding AE. A case control study of Leber's hereditary optic neuropathy. Brain 1996;119:1481-6.
34. Johns DR, Berman J. Alternative simulataneous complex I mitochondrial DNA mutations in Leber's hereditary optic neuropathy. Biochem Biophys Res Commun 1991;174:1324-30.
35. Johns DR, Heher KL, Miller NR, Smith KH. Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation. Arch Ophthalmol 1993;111:495-8.
36. Howell N. Leber hereditary optic neuropathy: how do mitochondrial DNA mutations cause degeneration of the optic nerve? J Bioenerg Biomembr 1997;29:165-73.
37. Torroni A, Petrozzi M, D'Urbano L, et al. Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet 1997;60:1107-21.
38. Li WH. Molecular evolution, Sunderland, MA: Sinauer, 1997.
39. Farrer LA, Myers RH, Connor L, Cupples A, Growdon JH. Segregation analysis reveals evidence of a major gene for Alzheimer disease. Am J Hum Genet 1991;48:1026-33.
40. Edland SD, Silverman JM, Peskind ER, Tsuang D, Wijsman E, Morris JC. Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology 1996;47:254-6.
41. Wooten GF, Currie LJ, Bennett JP, Harrison MB, Trugman JM, Parker WD Jr. Maternal inheritance in Parkinson's disease. Ann Neurol 1997;41:265-8.
42. Mutisya EM, Bowling AC, Beal MR Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 1994;63:2179-84.
43. Simonian NA, Hyman BT. Functional alternations in Alzheimer's disease: diminution of cytochrome c oxidase in the hippocampal formation. J Neuropathol Exp Neurol 1993;52:580-5.
44. Mizuno Y, Ikebe S, Hattori N, et al. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochem Biophys Acta 1995;1271:265-74.
45. Shults CW, Haas RH, Passov D, Beal MR Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol 1997;42:261-4.
46. Molina JA, de Bustos F, Jimenez-Jimenez FJ, et al. Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from patients with Alzheimer's disease. Neurology 1997;48:636-8.
47. Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40:663-71.
48. Swerdlow RH, Parks JK, Cassarino DS, et al. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 1997;49:918-25.
49. Schon EA, Shoubridge EA, Moraes CT. Cybrids in Alzheimer's disease: a cellular model of disease? Neurology 1998;51:326.
50. Shoffner JM, Brown MD, Torroni A, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993;17:171-84.
51. Hutchin T, Cortopassi G, A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci USA 1995;92:6892-5.
52. A4336G mutation with Alzheimer's and Parkinson's disease. Clin Genet 1997;45:109-10.
53. Hutchin TP, Heath PR, Pearson RC, Sinclair AJ. Mitochondrial DNA mutations in Alzheimer's disease, Biochem Biophys Res Commun 1997;241:221-5.
54. Davis RE, Miller S, Herrnstadt C, et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci USA 1997;94:4526-31.
55. Wallace DC, Stugard C, Murdock D, Schurr T, Brown MD. Ancient mtDNA sequences in the human nuclear genome: a potential source of erorrs in identifying pathogenic mutations. Proc Natl Acad Sci USA 1997;94:14900-5.
56. Hirano M, Shtilbans A, Mayeux R, et al. Apparent mtDNA heteroplasmy in Alzheimer's disease patients and normals due to PCR amplification of nuclear-embedded mtDNA pseudogenes. Proc Natl Acad Sci USA 1997;94:14894-9.
57. Hayer E. Mitochondrial and nuclear genetic contribution of female founders to a contemporary population in northeast Quebec. Am J Hum Genet 1994;56:1450-5.
58. Jorde LB, Bamshad MJ, Watkins WS, et al. Origins and affinities of modern humans: a comparison of mitochondrial and nuclear genetic data, Ant J HUM Genet 1995;57:523-38.
59. Hegele RA, Zinman B, Hanley AJG, Harris S, Connely PW. A common mtDNA polymorphism associated with variation in plasma triglyceride concentration. Ant J Hum Genet 1997;60:1552-5.
60. Ozawa T, Katsumata K, Hayakawa M, Yoneda M, Tanaka M, Sugiyama S. Mitochondrial DNA mutations and survival rate. Lancet 1995;345:189.
61. Tanaka M, Gong JS, Zhang J, Yoneda M, Yagi K. Mitochondrial genotype associated with longevity. Lancet 1998;351:185-6.
62. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992;1:368-71.
63. Vilarinho L, Santorelli FM, Rosas MJ, Tavares C, Melo-Pires M, DiMauro S. The mitochondrial A3243G mutation presenting as severe cardiomyopathy. J Med Genet 1997;34:607-9.
64. Petruzzella V, Moracs CT, Sano MC, Bonilla E, DiMauro S, Schon EA. Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243. Hum Mol Genet 1994;3:449-54.
65. Chinnery PF, Zwijnenburg PJG, Howell N, et al. Nonrandom tissue distribution of mutant mitochondrial DNA, Am J Med Genet (in press).